TGen News & Press Releases : Arizona Starts New Era With Bioscience Ceremony

TGen News & Press Releases

NAU-TGen study finds West Nile Virus now a permanent part of Arizona ecosystem

Posted Tuesday January 15, 2019

New technology allows better tracking of potentially deadly infection

Flinn Foundation awards ‘Prevent HAARM’ grant to C-Path and TGen

Posted Tuesday January 8, 2019

$400,000 grant aims to develop a genomic surveillance system to respond to antimicrobial resistant pathogens

TGen North partners with NARBHA Institute to promote human health

Posted Wednesday November 14, 2018

‘TGen One Health Collaborative’ uses holistic approach to connect human health and the environment

How did a deadly tropical fungus get to the temperate environs of the Pacific Northwest?

Posted Wednesday January 17, 2018

TGen-led study points to opening of the Panama Canal as the gateway of pathogen migration from Brazil to Canada

DxNA LLC receives a de novo regulatory clearance by the FDA for the GeneSTAT.MDx™ Coccidioides Test on the GeneSTAT® Analyzer - the only FDA cleared molecular test for Valley Fever

Posted Wednesday December 6, 2017

With technology developed by TGen, the test allows for rapid definitive diagnosis of Valley Fever.

TGen is one of 25 research groups sharing $9 million to combat drug-resistant bacteria

Posted Monday October 23, 2017

U.S. Centers for Disease Control announces creation of pilot projects geared to protect public health

DxNA LLC Announces 510(K) Submission of the GeneSTAT® Analyzer and GeneSTAT® Coccidioides Assay

Posted Monday July 10, 2017

Precision test backed by expertise of Valley Fever Center for Excellence; incorporates technology developed by TGen

Breakthrough Lyme disease test is the ‘next generation’ of diagnostics

Posted Tuesday February 28, 2017

Crowd funding campaign launches to start clinical study for TGen-developed diagnostic test

U.S. issues patent for Valley Fever detection technology developed by TGen and NAU

Posted Tuesday August 2, 2016

Test for dust-borne fungal infection created by TGen and NAU is licensed to DxNA

MRSA detection technology developed by TGen-NAU is granted first patent

Posted Wednesday June 15, 2016

Test for 'superbug' bacterial infections created by DxNA under license from TGen-NAU

Prev
[1]
2
Next

Search

Media Contact

Steve Yozwiak
[email protected]
602-343-8704

Newsletter

News Archive

View Media Release Archive